Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Associations Between Serum Magnesium Concentrations and Polycystic Ovary Syndrome Status: A Systematic Review and Meta-Analysis Publisher Pubmed



Babapour M1 ; Mohammadi H2 ; Kazemi M3 ; Hadi A4 ; Rezazadegan M1 ; Askari G2
Authors
Show Affiliations
Authors Affiliations
  1. 1. Student Research Committee, Department of Community Nutrition, School of Nutrition and Food Science, Isfahan University of Medical Sciences, Isfahan, Iran
  2. 2. Food Security Research Center and Department of Community Nutrition, School of Nutrition and Food Science, Isfahan University of Medical Sciences, PO Box 81745, Isfahan, Iran
  3. 3. Division of Nutritional Sciences, Human Metabolic Research Unit, Cornell University, Ithaca, NY, United States
  4. 4. Halal Research Center of IRI, FDA, Tehran, Iran

Source: Biological Trace Element Research Published:2021


Abstract

Magnesium (Mg) is the second most frequent intracellular cation in humans with a critical role in insulin metabolism and glucoregulation. Women with polycystic ovary syndrome (PCOS) often present with insulin resistance and impaired glucoregulatory status; however, their Mg status remains unclear. Therefore, we aimed to conduct a systematic review and meta-analysis to evaluate serum Mg concentration in women with PCOS and compare it with that of controls without PCOS. Online databases of PubMed, Scopus, Cochrane Library, and ISI Web of Science were searched for studies evaluating the relationship between Mg concentrations and PCOS status until October 2019. Pooled weighted mean differences (WMDs) of serum Mg levels were calculated using random effects models. A total of eight studies (10 arms; n = 2026 women) were included. Pooled effect sizes, expressed as WMD and 95% CI, revealed decreased serum Mg concentrations in women with PCOS compared with controls (− 0.09 (− 0.17, − 0.02) mmol/L; P = 0.01). However, significant heterogeneity was detected across the studies (I2 = 98.0%, P < 0.001). Despite the classification of studies based on baseline BMI classes, we did not detect the potential source of the observed heterogeneity. Subgroup analysis showed that overweight and obese women (BMI ≥ 25 kg/m2, 0.07 mmol/L (− 0.14, − 0.01); P = 0.02) with PCOS had lower magnesium concentrations than normal women (BMI < 25 kg/m2, − 0.11 (− 0.25, 0.04) mmol/L; P = 0.14) compared with the control group. Serum Mg concentrations appear to be declined in overweight or obese women with PCOS, which may warrant screening and management of Mg status in this clinical population. High-quality studies are needed to elucidate the relationship between Mg concentrations and the development of PCOS. © 2020, Springer Science+Business Media, LLC, part of Springer Nature.
Other Related Docs
23. Cardiometabolic Risk Factors in Polycystic Ovary Syndrome, Pakistan Journal of Medical Sciences (2012)
33. Does Carotid Intima-Media Thickness Have Relationship With Polycystic Ovary Syndrome?, International Journal of Preventive Medicine (2013)
39. Magnesium Intake and Lung Cancer Risk: A Systematic Review and Meta-Analysis, International Journal for Vitamin and Nutrition Research (2021)
42. Chromium Supplementation and Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis, Journal of Trace Elements in Medicine and Biology (2017)